Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2019
Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) StudyAntoni Noguera-Julian, Joan Calzada-Hernández, Folke Brinkmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
A Rare Mutation in SPLUNC1 Affects Bacterial Adherence and Invasion in Meningococcal DiseaseBayarchimeg Mashbat, Evangelos Bellos, Stephanie Hodeib, et al.
Frontiers in Immunology|December 20, 2023
Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibitionAlice Burleigh, Elena Moraitis, Eman Al Masroori, et al.
BMC Medical Research Methodology|February 21, 2022
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trialRebecca M Turner, Anna Turkova, Cecilia L Moore, et al.
Nature Genetics|August 10, 2010
Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal diseaseSonia Davila, Victoria J Wright, Chiea Chuen Khor, et al.
HIV Medicine|October 24, 2024
HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta surveyGeorgina Fernandes, Elizabeth Chappell, Tessa Goetghebuer, et al.
Plos One|April 24, 2018
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trialAnna Turkova, Cecilia L Moore, Karina Butler, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System SyndromeMarisol Perez-Toledo, Sian E Faustini, Sian E Jossi, et al.
Pediatrics|January 2, 2004
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsisPhil Barton, Andre C Kalil, Simon Nadel, et al.
The Journal of Infectious Diseases|August 15, 2020
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU)Kimberley Jefferies, Simon B Drysdale, Hannah Robinson, et al.
Pageof 13